# US 2021/0278427 A1 · Cartridges and Instruments for Sample Analysis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0278427 A1
- Document ID: US20210278427A1
- Status: Published application
- Kind: A1
- Application number: 17/211,212
- Filed: 2021-03-24
- Published: 2021-09-09
- Earliest claimed: 2013-11-18
- Assignees: IntegenX Inc.
- Applicants: Integenx Inc.
- Inventors: James Ogg; David Eberhart; William D. Nielsen; Helen Franklin; Stevan B. Jovanovich
- Web page: https://patentgrep.com/patent/US20210278427A1

## CPC

- G01N 35/00663: {of consumables}
- B01L 3/502: {with fluid transport, e.g. in multi-compartment structures}
- B01L 3/502715: {characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces}
- B01L 3/50273: {characterised by the means or forces applied to move the fluids}
- B01L 3/502738: {characterised by integrated valves (throttle valves in microfluidic sample containers B01L3/502746)}
- B01L 3/502746: {characterised by the means for controlling flow resistance, e.g. flow controllers, baffles or throttle valves}
- B01L 7/52: {with provision for submitting samples to a predetermined sequence of different temperatures, e.g. for treating nucleic acid samples}
- C12Q 1/6818: involving interaction of two or more labels, e.g. resonant energy transfer
- C12Q 1/686: Polymerase chain reaction [PCR]
- C12Q 1/6888: for detection or identification of organisms
- B01L 2200/026: Fluid interfacing between devices or objects, e.g. connectors, inlet details
- B01L 2200/027: for microfluidic devices
- B01L 2200/04: Exchange or ejection of cartridges, containers or reservoirs
- B01L 2200/0689: Sealing
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2200/16: Reagents, handling or storing thereof
- B01L 2300/044: pierceable, e.g. films, membranes
- B01L 2300/0627: Sensor or part of a sensor is integrated
- B01L 2300/0645: Electrodes
- B01L 2300/0672: Integrated piercing tool
- B01L 2300/0816: Cards, e.g. flat sample carriers usually with flow in two horizontal directions
- B01L 2300/0864: comprising only one inlet and multiple receiving wells, e.g. for separation, splitting
- B01L 2300/0867: Multiple inlets and one sample wells, e.g. mixing, dilution
- B01L 2300/087: Multiple sequential chambers
- B01L 2300/0887: Laminated structure
- B01L 2300/12: Specific details about materials
- B01L 2300/123: Flexible; Elastomeric
- B01L 2300/18: Means for temperature control
- B01L 2300/1827: using resistive heater
- B01L 2400/0421: electrophoretic flow
- B01L 2400/0478: pistons
- B01L 2400/0487: fluid pressure, pneumatics
- B01L 2400/0622: distribution valves, valves having multiple inlets and/or outlets, e.g. metering valves, multi-way valves
- B01L 2400/0638: membrane valves, flap valves
- B01L 2400/0644: rotary valves
- B01L 2400/0655: pinch valves
- G01N 2035/00673: {of reagents}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Provided herein are instruments and cartridges for processing samples. The cartridges include fluidic circuits in which fluid movement can be regulated by diaphragm valves. In certain cartridges, deformable material providing a diaphragm contacts an interface in the instrument that actuates the diaphragm directly, without intervening actuation layer. Certain cartridges have a plurality of fluidic circuits and fluid distribution channels or pneumatic distribution channels configured to deliver fluids or pneumatic pressure to any of the fluidic circuits, selectively. Certain cartridges have compartments containing on-board reagents. Compartments can be closed by a film attached to a body the cartridge through a heat seal.

## Claims

### Claim 1

A system, comprising a cartridge and a cartridge interface configured to receive the cartridge,
the cartridge comprising:
a cartridge body having a valve seat recessed into a surface of the cartridge body; and
a deformable layer thermally bonded to the surface of the cartridge body and covering the valve seat, wherein the deformable layer comprises a non-homogenous material having a first side configured to contact a heater and a second side contacting the body, the first side having a higher melting temperature than the second side; and
the cartridge interface being further configured to supply positive pressure or negative pressure to at least a portion of the deformable layer covering the valve seat.

### Claim 2 (depends on 1)

A method of operating the system of claim 1, the method comprising:
engaging the cartridge with the cartridge interface; and
supplying positive pressure or negative pressure to at least a portion of the deformable layer covering the valve seat.

### Claim 3

A method of actuating a valve in a cartridge system, the method comprising:
applying positive pressure or negative pressure to at least one portion of a deformable layer that is thermally bonded to a surface of a cartridge body and covers a valve seat recessed into the surface of the cartridge body, thereby actuating the deformable material into or out of contact with the valve seat,
wherein the deformable layer comprises a non-homogenous material having a first side configured to contact a heater and a second side contacting the body, the first side having a higher melting temperature than the second side.

### Claim 4 (depends on 3)

The method of claim 3 further comprising engaging the cartridge body with a cartridge interface configured to supply the positive pressure or the negative pressure to the at least one portion of the deformable layer.

### Claim 5

A cartridge comprising:
a cartridge body having a valve seat recessed into a surface of the cartridge body; and
a deformable layer thermally bonded to the surface of the cartridge body and covering the valve seat, wherein the deformable layer comprises a non-homogenous material having a first side configured to contact a heater and a second side contacting the body, the first side having a higher melting temperature than the second side.

### Claim 6 (depends on 5)

The cartridge of claim 5, wherein the non-homogenous material comprises a laminate.

### Claim 7 (depends on 5)

The cartridge of claim 5, wherein the non-homogenous material is not an elastomeric material.

### Claim 8 (depends on 5)

The cartridge of claim 5, wherein non-homogenous material is structurally configured for plastic deformation.

### Claim 9 (depends on 5)

The cartridge of claim 5, wherein at least one portion of the deformable layer comprises a permanent deformation.

### Claim 10 (depends on 5)

The cartridge of claim 5, wherein the valve seat has a curved shape that is concave with respect to the surface.

### Claim 11 (depends on 5)

The cartridge of claim 5 further comprising a valve inlet and a valve outlet on opposing sides of the valve seat and a fluid channel in fluidic communication with the valve inlet and the valve outlet.

### Claim 12 (depends on 11)

The cartridge of claim 11 further comprising a reaction chamber in fluidic communication with the fluid channel.

### Claim 13 (depends on 5)

A method, comprising engaging the cartridge of claim 5 with a cartridge interface configured to supply positive pressure or negative pressure to at least a portion of the deformable layer covering the valve seat.

### Claim 14 (depends on 13)

The method of claim 13 further comprising supplying positive pressure or negative pressure to at least a portion of the deformable layer covering the valve seat, thereby actuating the deformable layer into or out of contact with the valve seat.

### Claim 15 (depends on 5)

A method of using the cartridge of claim 5, the method comprising:
(a) providing a reaction mixture comprising:
(i) a sample comprising mammalian DNA;
(ii) reagents for amplifying short tandem repeats (STRs) in the mammalian DNA; and
(iii) a mammalian-specific probe selected to be amplified in a STR reaction, the mammalian-specific probe including a label that is distinguishable from the labeled primers;
(b) performing the STR reaction in the cartridge of claim 5, wherein performing the STR reaction comprises:
(i) amplifying the STRs in the mammalian DNA; and
(ii) amplifying the mammalian-specific probe;
(c) detecting an amount of amplified mammalian-specific probe in the reaction; and
(d) optionally, stopping the STR reaction based on an amount of amplified mammalian-specific probe detected.

### Claim 16 (depends on 15)

The method of claim 15, wherein the reagents comprise one or more of labeled primers, nucleotides, and polymerase.

### Claim 17 (depends on 15)

The method of claim 15, wherein detecting an amount of amplified mammalian specific probe in the reaction occurs over a first period of time.

### Claim 18 (depends on 15)

The method of claim 15, wherein detecting an amount of amplified mammalian specific probe in the reaction comprises performing real-time PCR.

### Claim 19 (depends on 15)

The method of claim 15 wherein the labels are fluorescent labels and the distinguishable label has a wavelength above or below the highest or lowest wavelength of labeled primers.

### Claim 20

A method comprising:
(a) providing a reaction mixture comprising:
(i) a sample comprising mammalian DNA;
(ii) reagents for amplifying short tandem repeats (STRs) in the mammalian DNA; and
(iii) a mammalian-specific probe selected to be amplified in a STR reaction, the mammalian-specific probe including a label that is distinguishable from the labeled primers;
(b) performing the STR reaction comprising:
(i) amplifying the STRs in the mammalian DNA; and
(ii) amplifying the mammalian-specific probe;
(c) detecting an amount of amplified mammalian-specific probe in the STR reaction; and
(d) optionally, stopping the STR reaction based on an amount of amplified mammalian-specific probe detected.
